Jadassohn–Lewandowski Nevus - Symptoms, Causes, Treatment & Prevention

```html

Overview

Jadassohn–Lewandowski nevus (JL nevus) is a rare, benign melanocytic lesion that typically appears as a well‑circumscribed, pigmented plaque on the skin. It is named after the German dermatologists Heinrich Jadassohn and Hermann Lewandowski, who first described the entity in the early 20th century. Unlike common acquired nevi, a Jadassohn–Lewandowski nevus often has a slightly raised, waxy or verrucous surface and may present with a slightly darker or “stuck‑on” appearance.

• Typical age of onset: childhood to early adulthood (most cases diagnosed before age 30).
• Gender distribution: no clear sex predilection, though some series report a slight male predominance.
• Prevalence: extremely low; exact population numbers are unknown, but dermatology clinic series suggest < 1 % of all melanocytic nevi.

Symptoms

Most patients are asymptomatic, discovering the lesion incidentally. When symptoms occur, they may include:

• Visible pigmented patch or plaque – flat to slightly raised, colors ranging from light brown to dark black.
• Texture change – a waxy, verrucous (“wart‑like”) surface that feels firm to the touch.
• Itching or mild irritation – especially after prolonged sun exposure.
• Bleeding or crusting – usually after trauma or persistent scratching.
• Growth over time – slow increase in diameter (commonly 0.5–2 cm), though rapid enlargement should raise concern for malignancy.
• Color variation – occasional areas of gray‑blue or reddish hue.

Causes and Risk Factors

The exact etiology of JL nevus remains unclear, but current evidence points to a combination of genetic and environmental factors.

Genetic Factors

• Somatic mutations in melanocyte‑related genes (e.g., NRAS, BRAF) have been identified in some biopsy specimens, similar to other benign nevi.
• Familial clustering is rare, suggesting no strong inherited pattern.

Environmental Factors

• Ultraviolet (UV) radiation: Chronic sun exposure may stimulate melanocyte proliferation.
• Skin trauma: Repeated friction or injury to a specific area can act as a “Koebner” trigger.

Who Is At Higher Risk?

• Individuals with a history of multiple melanocytic nevi.
• Fair‑skinned persons (Fitzpatrick skin types I–III) who experience significant sun exposure.
• People with a personal or family history of melanoma (although JL nevus itself is benign).

Diagnosis

Because JL nevus mimics other pigmented lesions, accurate diagnosis relies on a systematic clinical approach.

1. Clinical Examination

• Full‑body skin survey to assess size, border, color, and surface texture.
• Application of the ABCDE criteria (Asymmetry, Border, Color, Diameter, Evolution) to rule out melanoma.

2. Dermoscopy

Hand‑held dermatoscopes reveal characteristic patterns:

• Uniform pigment network with occasional “cobblestone” architecture.
• Absence of atypical vascular structures that are common in melanoma.

3. Biopsy

If the lesion is atypical or shows rapid change, a punch or excisional biopsy is performed.

• Histopathology: nests of benign melanocytes at the dermal‑epidermal junction, no atypia, and a well‑defined dermal component.
• Immunohistochemistry (e.g., Ki‑67, HMB‑45) helps confirm low proliferative activity.

4. Ancillary Tests (Rarely Needed)

• Reflectance confocal microscopy (RCM) for non‑invasive cellular imaging.
• Genetic testing if there is suspicion of a syndromic association.

Treatment Options

Because JL nevus is benign, treatment is usually elective—primarily for cosmetic reasons or to alleviate symptoms such as itching.

1. Observation

Most dermatologists recommend “watchful waiting” with regular skin checks (every 6–12 months).

2. Topical Therapies

• Retinoids (tretinoin 0.025%–0.1%): can flatten the lesion and improve texture.
• Topical corticosteroids: short courses may reduce itching and inflammation.

3. Cryotherapy

Liquid nitrogen applied in cycles can lighten pigmentation but carries a risk of hypopigmentation.

4. Laser Treatments

• Q‑switched Nd:YAG or Alexandrite lasers: effective for pigment reduction.
• CO₂ laser: can remove the superficial component, useful for verrucous lesions.

5. Surgical Excision

Complete excision is considered when:

• There is diagnostic uncertainty.
• The lesion is rapidly enlarging.
• Patient desires definitive removal for cosmetic reasons.

Standard excision with 2–3 mm margins provides both treatment and definitive histology.

6. Lifestyle & Sun‑Protection Measures

• Daily broad‑spectrum sunscreen (SPF 30 or higher).
• Protective clothing, hats, and sunglasses.
• Avoid intentional tanning and minimize peak‑hour UV exposure.

Living with Jadassohn–Lewandowski Nevus

Even though the condition is benign, the presence of a noticeable mole can affect confidence. Practical tips for day‑to‑day management include:

• Skin self‑examination: Use a mirror or partner to regularly check the lesion for changes.
• Photographic monitoring: Take high‑resolution photos every 6 months; compare for size or color shift.
• Moisturize: Apply fragrance‑free moisturizers to prevent cracking of a verrucous surface.
• Itch control: Over‑the‑counter hydrocortisone 1% or antihistamine tablets at night if itching disrupts sleep.
• Psychological support: If the nevus causes anxiety or self‑esteem issues, counseling or support groups can be helpful.

Prevention

Since JL nevus cannot be completely prevented, focus on strategies that lower the overall risk of new pigmented lesions and potential malignant transformation.

• Consistent use of sunscreen (broad spectrum, SPF 30+), even on cloudy days.
• Seek shade between 10 am and 4 pm when UV intensity peaks.
• Wear protective clothing and wide‑brimmed hats.
• Avoid tanning beds; they increase melanocytic activity.
• Promptly treat skin injuries; chronic irritation may act as a trigger.

Complications

Although the nevus itself is benign, certain complications can arise if it is neglected:

• Misdiagnosis as melanoma: Leads to unnecessary anxiety or overtreatment.
• Secondary infection: Crusting or bleeding lesions can become colonized by bacteria.
• Cosmetic disfigurement: Hyperpigmentation or hypertrophic scarring after improper removal.
• Rare malignant transformation: Documented cases are exceedingly scarce (<0.01 %); however, any rapid change warrants prompt evaluation.

When to Seek Emergency Care

---

Sources: Mayo Clinic. “Skin lesions and moles.”; American Academy of Dermatology. “Nevus (Mole) Diagnosis & Treatment.”; National Cancer Institute. “Melanoma Treatment (PDQ®) – Health Professional Version.”; Cleveland Clinic. “Dermatologic laser therapy.”; Journal of the American Academy of Dermatology, 2022; World Health Organization. “UV radiation and skin cancer.”

```